Alzheimer’s therapy pulled from PBAC

By Megan Brodie 2 weeks ago | In Products, Reimbursement
  • 2 weeks ago

3 July 2024 Eisai has withdrawn its highly anticipated early Alzheimer’s therapy LEQEMBI (lecanemab) from…

This is subscriber-only content. Please login to continue reading.